Sort
10,766 grants matching “checkpoint inhibitor”
SPORE in Brain Cancer
$2,088,365Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2024 · CA
Strategies for Cancer Immunotherapy Development: Preclinical Studies
$2,088,156Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
SPORE in Breast Cancer
$2,088,032Jennifer A Pietenpol · Vanderbilt University Medical Center · P50 · FY2020 · CA
Clinical evaluation of a novel AKT/PDK1 inhibitor, PHT-427, for the treatment of multi-field actinitc keratoses
$2,085,765Garth Powis · Phusis Therapeutics, Inc. · R44 · FY2025 · CA
University of Wisconsin Prostate SPORE
$2,085,688David F Jarrard · University Of Wisconsin-Madison · P50 · FY2024 · CA
The University of Texas MD Anderson Cancer Center SPORE in Melanoma
$2,083,190Patrick Hwu · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$2,079,438Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL
Computational studies of cancer immunotherapy
$2,073,990Eytan Ruppin · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
The University of Texas MD Anderson Cancer Center SPORE in Melanoma
$2,070,386Michael Davies · University Of Tx Md Anderson Can Ctr · P50 · FY2023 · CA
Preclinical drug development in pancreatic cancer
$2,069,338Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
SPORE in Brain Cancer
$2,069,263Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA
Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs
$2,067,796Peter Karl Sorger · Harvard Medical School · U54 · FY2019 · CA
Molecularly Targeted Radiosensitization of Locally Advanced Cancers
$2,066,150Theodore S Lawrence · University Of Michigan At Ann Arbor · P50 · FY2023 · CA
Centers for Cancer Systems Therapeutics (CaST)
$2,065,461Andrea Califano · Columbia University Health Sciences · U54 · FY2019 · CA
Brain Tumor Clinical and Clinical Research Program
$2,062,121Mark Gilbert · Division Of Basic Sciences - Nci · ZID · FY2019 · CA
University of Wisconsin Prostate SPORE
$2,061,062David F Jarrard · University Of Wisconsin-Madison · P50 · FY2023 · CA
The University of Texas MD Anderson Cancer Center SPORE in Melanoma
$2,058,691Michael Davies · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
$2,058,319Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Deciphering LKB1-associated immunotherapy resistance in lung adenocarcinoma (LUAD)
$2,055,632Haian Fu · Emory University · P01 · FY2024 · CA
SPORE in Brain Cancer
$2,051,421Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2023 · CA
SPORE in Brain Cancer
$2,051,421Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
SPORE in Brain Cancer
$2,051,421Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
Head and Neck Cancer SPORE at the University of Wisconsin
$2,049,112Paul M Harari · University Of Wisconsin-Madison · P50 · FY2024 · CA
Centers for Cancer Systems Therapeutics (CaST)
$2,041,589Andrea Califano · Columbia University Health Sciences · U54 · FY2020 · CA
Preclinical GEM and GDA Models of Primary and Metastatic Melanoma
$2,041,466Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA